A Systematic Review of Barriers and Solutions in Teacher Training in Artificial Intelligence
Minerva · 08.05.2026 · 7 (20) · 13-24
DOI: 10.47460/minerva.v7i20.307 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Minerva, online erschienen am 08.05.2026. Verfasst von Edwin Julio Colonia Villarreal. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This systematic review analyzed the main barriers and solutions related to teacher training in artificial intelligence in higher education. Following the \textit{PRISMA} protocol, 428 records were identified in \textit{Scopus}, \textit{Web of Science}, \textit{ERIC}, and \textit{ScienceDirect}, from which 18 studies of high methodological quality were finally selected. The findings revealed technological, pedagogical, organizational, and ethical barriers, with particular emphasis on insufficient digital infrastructure, the lack of specific didactic strategies, and limited institutional governance. The most effective solutions included communities of practice, continuing professional development, teacher mentoring, and sustainable institutional policies. The review concludes that the integration of AI in higher education requires a systemic transformation of universities, rather than isolated technical training alone.
Zitieren
APA
Villarreal, E. J. C. (2026). A Systematic Review of Barriers and Solutions in Teacher Training in Artificial Intelligence. Minerva, 7(20), 13-24. https://doi.org/10.47460/minerva.v7i20.307
Vancouver
Villarreal EJC. A Systematic Review of Barriers and Solutions in Teacher Training in Artificial Intelligence. Minerva. 2026;7(20):13-24. doi:10.47460/minerva.v7i20.307
BibTeX
@article{Villarreal2026,
author = {Villarreal, Edwin Julio Colonia},
title = {A Systematic Review of Barriers and Solutions in Teacher Training in Artificial Intelligence},
journal = {Minerva},
year = {2026},
volume = {7},
number = {20},
pages = {13--24},
doi = {10.47460/minerva.v7i20.307}
}
EUVIMED